Basera Tariro J, Ncayiyana Jabulani, Engel Mark E
Department of Epidemiology & Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Medicine, Faculty of Health Sciences University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
BMJ Open. 2017 Jul 18;7(7):e012636. doi: 10.1136/bmjopen-2016-012636.
Latent tuberculosis infection (LTBI) remains a major public health problem and one of the major contributors to the pool of active tuberculosis cases. The true burden of LTBI in Africa is not known. Early modelling studies estimate that over 33% of the world's population is infected with latent tuberculosis. We propose conducting a systematic review and a meta-analysis to evaluate the burden and risk factors of LTBI in Africa reported in studies from 2000 to 2017.
We will include cross-sectional studies, cohort studies and case-control studies estimating either tuberculin skin test (TST) or interferon-gamma release assay (IGRA) confirmed prevalence of LTBI and associated risk factors among people in African countries. A comprehensive search of relevant literature will be conducted on electronic databases using common and medical subject heading (MeSH) terms for LTBI, and an African search filter. Risk of bias will be evaluated by assessing all qualifying full-text articles for quality and eligibility using a quality score assessment tool. Standardised data extraction will be carried out after which prevalence estimates will be pooled using random-effects models in Stata V.13. Where there is sufficient data , subgroup meta-analyses will be conducted by risk factors including participant's age group, occupation, location and HIV status. This systematic review will be reported according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses Protocols 2015 Statement.
No ethical issues were foreseen given that this was a protocol for a systematic review of published studies. The results of this study will be published in a peer-reviewed journal and presented at conferences.
Systematic review registration: PROSPERO CRD42016037997.
潜伏性结核感染(LTBI)仍然是一个主要的公共卫生问题,也是活动性结核病例的主要来源之一。非洲LTBI的实际负担尚不清楚。早期的模型研究估计,全球超过33%的人口感染了潜伏性结核。我们建议进行一项系统评价和荟萃分析,以评估2000年至2017年在非洲开展的研究中所报告的LTBI的负担和危险因素。
我们将纳入横断面研究、队列研究和病例对照研究,这些研究需估计结核菌素皮肤试验(TST)或干扰素-γ释放试验(IGRA)确诊的非洲国家人群中LTBI的患病率及相关危险因素。将使用LTBI的通用术语和医学主题词(MeSH),以及一个非洲检索过滤器,在电子数据库中全面检索相关文献。将通过使用质量评分评估工具评估所有符合条件的全文文章的质量和合格性,来评价偏倚风险。将进行标准化数据提取,之后使用Stata V.13中的随机效应模型汇总患病率估计值。如果有足够的数据,将按危险因素进行亚组荟萃分析,这些危险因素包括参与者的年龄组、职业、地点和艾滋病毒感染状况。本系统评价将根据《系统评价和荟萃分析方案的首选报告项目2015声明》进行报告。
鉴于这是一项已发表研究的系统评价方案,未预见伦理问题。本研究结果将发表在同行评审期刊上,并在会议上展示。
系统评价注册号:PROSPERO CRD42016037997。